Fondation Franc.Cancerologie Digestive
Fondation Franc.Cancerologie Digestive is recorded as a service provider in 6 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 6 of 6 trials · Latest update first
PRODIGE 88 (FFCD 2002) CIRCULATE MRD PAC: A phase III multicentric, open-label, randomized study of chemotherapy in patients with positive ctDNA after surgery and adjuvant chemotherapy for high-risk stage II and stage III colorectal cancer
Sponsor Centre Hospitalier Universitaire De Dijon
- Start (EU)
- Latest update
- Estimated end
- Not reported
PRODIGE 98 (FFCD 2105) – AMPIRINOX: Randomized, multicenter Phase 3 trial of adjuvant chemotherapy with modified FOLFIRINOX versus capecitabine or gemcitabine in patients with resected ampullary adenocarcinoma
Sponsor Centre Hospitalier Universitaire De Dijon
- Start (EU)
- Latest update
- Estimated end
- Not reported
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II
Sponsor Centre Hospitalier Universitaire De Dijon
- Start (EU)
- Latest update
- Estimated end
- Not reported
ENGIC 02 - PRODIGE 86-FOLFIRINOX SBA- Phase II randomized trial evaluating modified FOLFIRINOX and FOLFOX in the treatment of locally advanced or metastatic small bowel adenocarcinoma
Sponsor Centre Hospitalier Universitaire De Dijon
- Start (EU)
- Latest update
- Estimated end
- Not reported
PRODIGE 87 FOXTROT II : Personalising and refining neo-adjuvant chemotherapy in locally advanced but resectable colon cancer in the elderly of 70 years old or more
Sponsor Centre Hospitalier Universitaire De Dijon
- Start (EU)
- Latest update
- Estimated end
PRODIGE 90 - FFCD 2204 - PREDIR-NEOREC - Neoadjuvant dostarlimab with short course radiotherapy in a watch-and-wait strategy for microsatellite unstable or mismatch repair-deficient locally advanced rectal cancer patients: a randomized phase II trial
Sponsor Centre Hospitalier Universitaire De Dijon
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Fondation Franc.Cancerologie Digestive?
The 2026-10-09 snapshot links Fondation Franc.Cancerologie Digestive to 6 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Project management, Safety reporting & pharmacovigilance, among 11 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Fondation Franc.Cancerologie Digestive?
The most frequently recorded therapeutic areas are Gastroenterology, Solid Tumor Oncology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Fondation Franc.Cancerologie Digestive conducted?
The linked trials record locations in 2 countries, including France, Italy. These are trial locations, not confirmed office locations or countries where Fondation Franc.Cancerologie Digestive delivered services.
What can this page tell me about Fondation Franc.Cancerologie Digestive's trial experience?
Browse 6 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Fondation Franc.Cancerologie Digestive. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Fondation Franc.Cancerologie Digestive